Poliovirus Receptor anticorps (AA 314-342) (PE)
-
- Antigène Voir toutes Poliovirus Receptor (PVR) Anticorps
- Poliovirus Receptor (PVR)
-
Épitope
- AA 314-342
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Poliovirus Receptor est conjugé à/à la PE
-
Application
- Western Blotting (WB), ELISA
- Specificité
- This PVR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 314-342 amino acids from the C-terminal region of human PVR.
- Purification
- Affinity purified
- Isotype
- IgG
- Top Product
- Discover our top product PVR Anticorps primaire
-
-
- Indications d'application
-
Approved: ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, no preservatives added
- Agent conservateur
- Without preservative
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
- Date de péremption
- 6 months
-
- Antigène
- Poliovirus Receptor (PVR)
- Autre désignation
- PVR / CD155 (PVR Produits)
- Synonymes
- anticorps PVR, anticorps CD155, anticorps HVED, anticorps NECL5, anticorps Necl-5, anticorps PVS, anticorps TAGE4, anticorps 3830421F03Rik, anticorps D7Ertd458e, anticorps Taa1, anticorps Tage4, anticorps mE4, anticorps necl-5, anticorps poliovirus receptor, anticorps PVR, anticorps Pvr
- Sujet
-
Name/Gene ID: PVR
Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4 - ID gène
- 5817
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
-